LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 7.01 | 17.25 | 720 | 389 | 1.8485 | 1.2928 | MN20160310_N02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 7.01 | 17.25 | 1 | 389 | 0.0026 | -0.4692 | MN20160310_N02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 7.01 | 17.25 | 1064 | 389 | 2.7317 | 1.5008 | MN20160310_N02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 8.98 | 17.25 | 5 | 445 | 0.0112 | -0.2321 | MN20160310_N02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 8.98 | 17.25 | 810 | 445 | 1.8199 | 1.2724 | MN20160310_N02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 8.98 | 17.25 | 1 | 445 | 0.0022 | -0.4552 | MN20160310_N02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 8.98 | 17.25 | 1108 | 445 | 2.4895 | 1.4294 | MN20160310_N02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 10.95 | 17.25 | 1 | 471 | 0.0021 | -0.4494 | MN20160310_N02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 10.95 | 17.25 | 867 | 471 | 1.8385 | 1.2722 | MN20160310_N02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 10.95 | 17.25 | 1 | 471 | 0.0021 | -0.4494 | MN20160310_N02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 10.95 | 17.25 | 1185 | 471 | 2.5129 | 1.4259 | MN20160310_N02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 12.91 | 17.25 | 5 | 494 | 0.0101 | -0.2257 | MN20160310_N02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 12.91 | 17.25 | 921 | 494 | 1.8611 | 1.2738 | MN20160310_N02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 12.91 | 17.25 | 1 | 494 | 0.0020 | -0.4446 | MN20160310_N02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 12.91 | 17.25 | 1255 | 494 | 2.5361 | 1.4238 | MN20160310_N02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 14.88 | 17.25 | 7 | 534 | 0.0131 | -0.1665 | MN20160310_N02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 14.88 | 17.25 | 990 | 534 | 1.8524 | 1.2651 | MN20160310_N02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 14.88 | 17.25 | 1 | 534 | 0.0019 | -0.4373 | MN20160310_N02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 14.88 | 17.25 | 1320 | 534 | 2.4699 | 1.4005 | MN20160310_N02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 16.85 | 17.25 | 8 | 655 | 0.0122 | -0.1362 | MN20160310_N02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 16.85 | 17.25 | 1061 | 655 | 1.6184 | 1.1922 | MN20160310_N02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 16.85 | 17.25 | 1 | 655 | 0.0015 | -0.4188 | MN20160310_N02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 16.85 | 17.25 | 1409 | 655 | 2.1493 | 1.3139 | MN20160310_N02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 18.82 | 17.25 | 8 | 800 | 0.0100 | -0.1296 | MN20160310_N02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 18.82 | 17.25 | 1176 | 800 | 1.4691 | 1.1439 | MN20160310_N02 | E17 |